These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12453820)

  • 1. Childhood vaccine purchase costs in the public sector: past trends, future expectations.
    Davis MM; Zimmerman JL; Wheeler JR; Freed GL
    Am J Public Health; 2002 Dec; 92(12):1982-7. PubMed ID: 12453820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in childhood vaccine purchase costs in the US public sector: 1996-2014.
    Chen W; Messonnier M; Zhou F
    Vaccine; 2016 Sep; 34(39):4706-4711. PubMed ID: 27522176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaps in vaccine financing for underinsured children in the United States.
    Lee GM; Santoli JM; Hannan C; Messonnier ML; Sabin JE; Rusinak D; Gay C; Lett SM; Lieu TA
    JAMA; 2007 Aug; 298(6):638-43. PubMed ID: 17684186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the pricing of childhood vaccines in the U.S. public sector.
    Chen W; Messonnier M; Zhou F
    Health Econ; 2018 Feb; 27(2):252-265. PubMed ID: 28660666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2009 Dec; 124 Suppl 5():S459-65. PubMed ID: 19948577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative cost analysis of the Vaccination Program for US-bound Refugees.
    Joo H; Maskery B; Mitchell T; Leidner A; Klosovsky A; Weinberg M
    Vaccine; 2018 May; 36(20):2896-2901. PubMed ID: 28919225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size of clinical trials and Introductory prices of prophylactic vaccine series.
    Weinberg SH; Butchart AT; Davis MM
    Hum Vaccin Immunother; 2012 Aug; 8(8):1066-70. PubMed ID: 22854668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financing immunizations in the United States.
    Hinman AR; Orenstein WA; Rodewald L
    Clin Infect Dis; 2004 May; 38(10):1440-6. PubMed ID: 15156483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Vaccine Advisory Committee 2008 vaccine financing recommendations: different point of view.
    Abramson JS
    Pediatrics; 2009 Dec; 124 Suppl 5():S569-70. PubMed ID: 19948592
    [No Abstract]   [Full Text] [Related]  

  • 15. U.S. childhood vaccine availability: legal, regulatory, and economic complexities.
    Strongin RJ
    NHPF Issue Brief; 2002 Nov; (785):1-20. PubMed ID: 12463233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine immunization services costs and financing in China, 2015.
    Yu W; Lu M; Wang H; Rodewald L; Ji S; Ma C; Li Y; Zheng J; Song Y; Wang M; Wang Y; Wu D; Cao L; Fan C; Zhang X; Liu Y
    Vaccine; 2018 May; 36(21):3041-3047. PubMed ID: 29685593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in patient charges for vaccines and well-child care.
    Freed GL; Clark SJ; Konrad TR; Pathman DE
    Arch Pediatr Adolesc Med; 1996 Apr; 150(4):421-6. PubMed ID: 8634739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine.
    Davis MM; Ndiaye SM; Freed GL; Kim CS; Clark SJ
    Pediatrics; 2003 Sep; 112(3 Pt 1):521-6. PubMed ID: 12949277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between pediatric combination vaccines and market effects.
    Behzad B; Jacobson SH; Jokela JA; Sewell EC
    Am J Public Health; 2014 Jun; 104(6):998-1004. PubMed ID: 24825198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings from case studies of state and local immunization programs.
    Fairbrother G; Kuttner H; Miller W; Hogan R; McPhillips H; Johnson KA; Alexander ER
    Am J Prev Med; 2000 Oct; 19(3 Suppl):54-77. PubMed ID: 11024331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.